Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin (Q44278786)

1 December 2017

Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin (English)

1 reference

1 December 2017

3

Lind L

1 reference

1 December 2017

4

Nyström F

1 reference

1 December 2017

Malmqvist K

1

1 reference

1 December 2017

Ohman KP

series ordinal

2

1 reference

1 December 2017

Kahan T

series ordinal

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Journal of Internal Medicine

1 December 2017

1 reference

1 December 2017

252

1 reference

1 December 2017

5

1 reference

1 December 2017

430-439

1 reference

Prognostic implications of left ventricular hypertrophy

1 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Angiotensin receptors and their antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

The changing face of sympathetic overactivity in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Insulin as a growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Serum insulin levels, 24-hour blood pressure profile, and left ventricular mass in nonobese hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Left ventricular mass is not related to insulin sensitivity in never-treated primary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Chronic leptin infusion increases arterial pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Regression of left ventricular hypertrophy in human hypertension with irbesartan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: the Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Influence of humoral and neurohormonal factors on cardiovascular hypertrophy in untreated essential hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

How to assess sympathetic activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Fasting serum insulin levels in essential hypertension. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Insulin sensitivity and the effects of insulin on renal sodium handling and pressor systems in essential hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

High plasma immunoreactive leptin level in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Receptor-mediated regional sympathetic nerve activation by leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Prognosis of left ventricular geometric patterns in the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

Insulin resistance and cardiovascular complications in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01053.X

10.1046/J.1365-2796.2002.01053.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference